October 26, 2025 · Read time: under 4 minutes
AIxBiotech – weekly brief
Reporting from Zug, Switzerland — Europe’s biotech hub
Presented by OUR SPONSOR
Traveling with Swiss or Lufthansa group?
With the Uptrip app you collect cards per flight which you can exchange for lounge access, points, miles, and even Frequent Flyer status. Referral code: AL-8B866938-E147. Sign up for free via this link, use referral code: AL-8B866938-E147 and start with 4 cards.
This week’s Biotech meets AI
3 headlines to be aware of
1️⃣ 🧬 Flagship Pioneering (creator of Moderna) launches Expedition Bio with $50 million for AI-native drug discovery.
The creator of Moderna is betting again — this time on an AI-driven biotech startup focused on oncology and immune programs, signaling AI’s shift from pilot to pipeline core.
🔗 Read more at Flagship Pioneering
2️⃣ 🧠 DeepMind’s Isomorphic Labs expands AI partnership with Novartis.
Their multi-target deal extends AlphaFold-based molecule design into metabolic and oncology indications — Big Pharma now treats AI as infrastructure, not experiments.
🔗 Read more at Reuters
3️⃣ 🧪 Insilico Medicine pushes AI-discovered fibrosis drug into Phase II trials.
Its IPF candidate is the first fully AI-originated small molecule to reach this stage — a regulatory milestone five years in the making.
🔗 Read more at BioPharma Dive
From the Biotech Frontier
➤ Eli Lilly to acquire MorphoSys AG for $2.7 billion, strengthening its oncology portfolio through AI-profiled antibodies and precision biomarkers as part of its R&D expansion strategy (Reuters).
➤ Bayer spins out its CropScience AI division into “Verda.AI,” a new entity focused on predictive plant genomics and molecule design for ag-biotech applications (Bloomberg)
➤ Regeneron and Recursion expand their computational drug-discovery partnership to include multi-omics data and phenotypic screening — a shift from tech vendor to co-developer model (Fierce Biotech)
AI Academy: The SOP rewriter prompt
When you face a complex lab protocol or SOP draft, ask your AI assistant:
“Rewrite this procedure for clarity and consistency. Use numbered steps, specify reagent concentrations and timing, flag ambiguous phrases, and add Q&A annotations for training.
💡 It turns messy procedures into clean, auditable docs your QA team will actually thank you for.
⚙️ AI Tools: Work smarter, not harder
1️⃣ 🧠 Notion Q2 AI Upgrade — Adds data-linked pages and spreadsheet-style reasoning so you can summarize project data without leaving your notes.
🔗 notion.so
2️⃣ ⚙️ Kern AI — Open-source platform for building domain-specific LLMs and annotation workflows, ideal for biotech teams training AI on scientific texts.
🔗 kern.ai
3️⃣ 📬 Superhuman for Teams — Now with AI auto-summaries for threaded email chains and follow-up suggestions — perfect for partner and regulatory threads.
🔗 superhuman.com
Partner with AIxBiotech
Reach biotech operators and leaders across Europe and the US. Sponsor a section or run a product spotlight.